Free Trial

AgeX Therapeutics (AGE) Institutional Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Institutional Ownership Changes (13F Filings) for AgeX Therapeutics (NYSE:AGE)

Current
Institutional Ownership
Percentage
12.50%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$42.99K
Number of
Institutional Sellers
(last 12 months)
0
Get AGE Insider Trade Alerts

Want to know when executives and insiders are buying or selling AgeX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AGE Institutional Buying and Selling by Quarter

AgeX Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/1/2024 Sigma Planning Corp286,425$110K0.0%+57.9%0.755%
11/6/2023 Sigma Planning Corp181,385$123K0.0%+29.8%0.478%
4/20/2023Strategic Wealth Investment Group LLC600$57K0.0%-99.3%0.002%
2/14/2023Susquehanna International Group LLP52,381$29K0.0%N/A0.138%
1/24/2023 Sigma Planning Corp134,977$74K0.0%+15.2%0.356%
10/21/2022Strategic Wealth Investment Group LLC82,010$46K0.0%-22.7%0.216%
8/11/2022 Sigma Planning Corp116,650$67K0.0%+33.1%0.307%
1/21/2022Strategic Wealth Investment Group LLC112,251$122K0.0%+20.8%0.296%
10/28/2021 Sigma Planning Corp88,200$83K0.0%+70.6%0.232%
8/17/2021 Bridgeway Capital Management LLC244,770$379K0.0%-19.7%0.645%
8/13/2021 Renaissance Technologies LLC75,059$116K0.0%-77.3%0.198%
8/13/2021 Sigma Planning Corp51,700$80K0.0%+120.0%0.136%
5/18/2021 Millennium Management LLC18,523$30K0.0%-82.3%0.049%
5/13/2021 Renaissance Technologies LLC330,500$535K0.0%+212.7%0.871%
2/10/2021 Renaissance Technologies LLC105,700$161K0.0%N/A0.280%
11/3/2020Strategic Wealth Designers57,325$46K0.0%+21.6%0.152%
10/23/2020 Defender Capital LLC.35,597$29K0.0%-17.4%0.094%
10/20/2020 Wedbush Securities Inc.67,927$55K0.0%N/A0.180%
8/31/2020 Bridgeway Capital Management Inc.154,770$147K0.0%N/A0.411%
8/14/2020 Bank of America Corp DE152,838$144K0.0%+8,238.1%0.406%
7/13/2020Strategic Wealth Designers47,157$45K0.0%N/A0.125%
6/19/2020 State Street Corp293,888$273K0.0%+11.8%0.780%
5/14/2020 Wells Fargo & Company MN44,474$41K0.0%+630.2%0.118%
5/14/2020 Defender Capital LLC.50,997$47K0.0%-63.1%0.135%
5/11/2020 State Street Corp293,888$273K0.0%+11.8%0.780%
5/1/2020 BlackRock Inc.1,143,580$1.06M0.0%-2.2%3.037%
(Data available from 1/1/2016 forward)

AGE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AGE shares?

During the previous two years, the following institutional investors and hedge funds held shares of AgeX Therapeutics shares: Sigma Planning Corp ($110K), and Strategic Wealth Investment Group LLC ($57K), Susquehanna International Group LLP ($29K).Learn more on AGE's institutional investors.

What percentage of AgeX Therapeutics stock is owned by institutional investors?

12.50% of AgeX Therapeutics stock is owned by institutional investors. Learn more on AGE's institutional investor holdings.

Which institutional investors have been buying AgeX Therapeutics stock?

The following institutional investors have purchased AgeX Therapeutics stock in the last 24 months: Sigma Planning Corp ($193.50K), and Susquehanna International Group LLP ($52.38K).

How much institutional buying is happening at AgeX Therapeutics?

Institutional investors have bought a total of 245,883 shares in the last 24 months. This purchase volume represents approximately $77.64K in transactions.

Which AgeX Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold AgeX Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($109.87K).

How much institutional selling is happening at AgeX Therapeutics?

Institutional investors have sold a total of 109,868 shares in the last 24 months. This volume of shares sold represents approximately $44.00K in transactions.


This page (NYSE:AGE) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners